Skip to main content
. Author manuscript; available in PMC: 2019 Nov 9.
Published in final edited form as: Leukemia. 2019 May 9;33(11):2599–2609. doi: 10.1038/s41375-019-0477-x

Figure 1:

Figure 1:

Figure 1:

Figure 1:

Figure 1:

Overall survival for alloHCT and CT with 5-year point estimate (1A), treatment-related mortality for alloHCT and CT with 5-year point estimate (1B), cumulative incidence of relapse for alloHCT and CT with 5-year point estimate (1C), disease-free survival for alloHCT and CT with 5-year point estimate (1D)